A Clinician's Perspective on Emerging Therapies and Managed Care Challenges in Vitiligo Management
In this discussion on vitiligo, Seemal Desai, M.D., FAAD, explores disease mechanisms, diagnostic approaches, emerging therapies, treatment optimization, managed care considerations and psychosocial support strategies, emphasizing personalized care while addressing access barriers and the integration of digital health technologies to improve patient outcomes.
EP. 1: Diagnostic Challenges and Treatment Impact in Vitiligo Management
November 11th 2024Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying disease subtypes and distinguishing vitiligo from other depigmentation disorders.
Watch
EP. 2: Exploring Emerging Therapies in Vitiligo
November 18th 2024The panelist discusses how emerging targeted therapies like Janus kinase inhibitors and combination treatment approaches are transforming vitiligo management, with treatment selection guided by disease patterns, progression rates and individual patient response, while acknowledging the need for systematic assessment and alternative strategies for treatment-resistant cases.
Watch
